B.C. Søndergaard

787 total citations
17 papers, 651 citations indexed

About

B.C. Søndergaard is a scholar working on Rheumatology, Pharmacology and Cancer Research. According to data from OpenAlex, B.C. Søndergaard has authored 17 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Rheumatology, 5 papers in Pharmacology and 5 papers in Cancer Research. Recurrent topics in B.C. Søndergaard's work include Osteoarthritis Treatment and Mechanisms (12 papers), Protease and Inhibitor Mechanisms (5 papers) and Inflammatory mediators and NSAID effects (5 papers). B.C. Søndergaard is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (12 papers), Protease and Inhibitor Mechanisms (5 papers) and Inflammatory mediators and NSAID effects (5 papers). B.C. Søndergaard collaborates with scholars based in Denmark, Australia and Germany. B.C. Søndergaard's co-authors include M.A. Karsdal, Per Qvist, Claus Christiansen, László B. Tankó, Kim Henriksen, S. Oestergaard, Anne‐Christine Bay‐Jensen, S.H. Madsen, Moustapha Kassem and Sophie Schaller and has published in prestigious journals such as Bone, Osteoarthritis and Cartilage and Clinical & Experimental Immunology.

In The Last Decade

B.C. Søndergaard

16 papers receiving 638 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B.C. Søndergaard Denmark 10 420 210 174 132 98 17 651
Johanne Martel‐Pelletier Canada 11 381 0.9× 245 1.2× 257 1.5× 67 0.5× 97 1.0× 12 614
Kirsty L. Culley United States 14 271 0.6× 88 0.4× 242 1.4× 129 1.0× 74 0.8× 20 489
Diana C. Brinson United States 10 261 0.6× 82 0.4× 226 1.3× 100 0.8× 82 0.8× 11 575
Amanda Villalvilla Spain 10 301 0.7× 160 0.8× 173 1.0× 56 0.4× 77 0.8× 14 526
Heba Ismail United Kingdom 12 212 0.5× 99 0.5× 261 1.5× 83 0.6× 52 0.5× 24 519
Meryem Blati Canada 6 434 1.0× 140 0.7× 351 2.0× 150 1.1× 59 0.6× 7 659
Frédéric Massicotte Canada 9 363 0.9× 150 0.7× 250 1.4× 40 0.3× 129 1.3× 18 559
Marie-Thérèse Corvol France 11 208 0.5× 72 0.3× 235 1.4× 63 0.5× 65 0.7× 18 588
C. Cherifi France 7 296 0.7× 124 0.6× 183 1.1× 71 0.5× 82 0.8× 12 445
Marcia L. Bliven United States 11 210 0.5× 127 0.6× 72 0.4× 54 0.4× 55 0.6× 28 459

Countries citing papers authored by B.C. Søndergaard

Since Specialization
Citations

This map shows the geographic impact of B.C. Søndergaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.C. Søndergaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.C. Søndergaard more than expected).

Fields of papers citing papers by B.C. Søndergaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.C. Søndergaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.C. Søndergaard. The network helps show where B.C. Søndergaard may publish in the future.

Co-authorship network of co-authors of B.C. Søndergaard

This figure shows the co-authorship network connecting the top 25 collaborators of B.C. Søndergaard. A scholar is included among the top collaborators of B.C. Søndergaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.C. Søndergaard. B.C. Søndergaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Andersson, Christina, P.A. Usher, Josephine B. Hebsgaard, et al.. (2014). Rapid-onset clinical and mechanistic effects of anti-C5aR treatment in the mouse collagen-induced arthritis model. Clinical & Experimental Immunology. 177(1). 219–233. 27 indexed citations
2.
Søndergaard, B.C., Philip Catalá-Lehnen, Angela Huebner, et al.. (2011). Mice over-expressing salmon calcitonin have strongly attenuated osteoarthritic histopathological changes after destabilization of the medial meniscus. Osteoarthritis and Cartilage. 20(2). 136–143. 30 indexed citations
3.
Søndergaard, B.C., et al.. (2011). 255 OSTEOARTHRITIC ARTICULAR CARTILAGE EXPRESSES THE PTH RECEPTOR; PTH EFFECTS CARTILAGE METABOLISM. Osteoarthritis and Cartilage. 19. S122–S123. 2 indexed citations
4.
Madsen, S.H., et al.. (2009). Cartilage formation measured by a novel PIINP assay suggests that IGF‐I does not stimulate but maintains cartilage formation ex vivo. Scandinavian Journal of Rheumatology. 38(3). 222–226. 9 indexed citations
8.
Tankó, László B., B.C. Søndergaard, S. Oestergaard, M.A. Karsdal, & Claus Christiansen. (2008). An update review of cellular mechanisms conferring the indirect and direct effects of estrogen on articular cartilage. Climacteric. 11(1). 4–16. 47 indexed citations
9.
Karsdal, M.A., et al.. (2007). 206 CARTILAGE DEGRADATION IS FULLY REVERSIBLE IN THE PRESENCE OF AGGRECANASE BUT NOT MATRIX METALLOPROTEINASE ACTIVITY. Osteoarthritis and Cartilage. 15. C120–C120. 1 indexed citations
10.
Olsen, Ann‐Karin, B.C. Søndergaard, I. Byrjalsen, et al.. (2006). Anabolic and catabolic function of chondrocyte ex vivo is reflected by the metabolic processing of type II collagen. Osteoarthritis and Cartilage. 15(3). 335–342. 39 indexed citations
11.
Sumer, E.U., Sophie Schaller, B.C. Søndergaard, László B. Tankó, & Per Qvist. (2006). Application of biomarkers in the clinical development of new drugs for chondroprotection in destructive joint diseases: a review. Biomarkers. 11(6). 485–506. 15 indexed citations
12.
Søndergaard, B.C., Kim Henriksen, S. Oestergaard, et al.. (2006). Relative contribution of matrix metalloprotease and cysteine protease activities to cytokine-stimulated articular cartilage degradation. Osteoarthritis and Cartilage. 14(8). 738–748. 112 indexed citations
13.
Sumer, E.U., B.C. Søndergaard, Jean‐Charles Rousseau, et al.. (2006). MMP and non-MMP-mediated release of aggrecan and its fragments from articular cartilage: a comparative study of three different aggrecan and glycosaminoglycan assays. Osteoarthritis and Cartilage. 15(2). 212–221. 50 indexed citations
15.
Søndergaard, B.C., Kim Henriksen, Sophie Schaller, et al.. (2006). Calcitonin directly attenuates collagen type II degradation by inhibition of matrix metalloproteinase expression and activity in articular chondrocytes. Osteoarthritis and Cartilage. 14(8). 759–768. 75 indexed citations
16.
Schaller, Sophie, Kim Henriksen, Pernille Høegh-Andersen, et al.. (2005). In Vitro, Ex Vivo , and In Vivo Methodological Approaches for Studying Therapeutic Targets of Osteoporosis and Degenerative Joint Diseases: How Biomarkers Can Assist?. Assay and Drug Development Technologies. 3(5). 553–580. 93 indexed citations
17.
Søndergaard, B.C., Kim Henriksen, Søren Østergaard, et al.. (2005). A2 GADD45β is novel mediator of MMP-13 gene expression during chondrocyte hypertrophy. Osteoarthritis and Cartilage. 13. S12–S13. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026